Brief: Initiator Pharma Decides Not To Exercise Option For Pain Asset
Dec 23 (Reuters) - Initiator Pharma A/S INIT.ST :
* INITIATOR PHARMA HAS DECIDED NOT TO EXERCISE THE OPTION
FOR AN
UNDISCLOSED PAIN ASSET
* CURRENT CASH POSITION WILL BE SUFFICIENT TO FUND ALL
PLANNED AND
COMMITTED ACTIVITIES THROUGH 2024
* PROFILE OF COMPOUND DOES NOT FULFILL OUR EVALUATION
CORNERSTONE
CRITERIA
Source text for Eikon: ID:nMFN7Y2th7
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD